ID: ALA4873592

Max Phase: Preclinical

Molecular Formula: C16H22N4

Molecular Weight: 270.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCn1c2ccccc2n2cc(C)nc12

Standard InChI:  InChI=1S/C16H22N4/c1-4-18(5-2)10-11-19-14-8-6-7-9-15(14)20-12-13(3)17-16(19)20/h6-9,12H,4-5,10-11H2,1-3H3

Standard InChI Key:  YSZOZVONWPEGBG-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily M member 2 348 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.38Molecular Weight (Monoisotopic): 270.1844AlogP: 2.94#Rotatable Bonds: 5
Polar Surface Area: 25.47Molecular Species: BASEHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.91CX LogP: 2.15CX LogD: -0.38
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.71Np Likeness Score: -1.71

References

1. Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z..  (2021)  Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors.,  225  [PMID:34416664] [10.1016/j.ejmech.2021.113750]

Source